Hormones and Your Heart: Why Doctors Keep Changing Their Minds
Part 1 of 4 in our series: Menopause Hormone Therapy and Your Heart
If you've ever asked your doctor about hormone therapy and gotten a vague, cautious answer — you're not alone. For decades, menopause hormone therapy (MHT) has been caught in a tug-of-war between excitement and fear. First, it was a near-magical fix for everything. It was then practically banned from the conversation. Now? It's making a serious comeback.
So why do doctors keep changing their minds? And more importantly, what does any of this mean for your heart?
Let's start at the beginning.
The 1980s: Hormones Were Basically a Superfood
Back in the late 1980s, the medical world was genuinely optimistic about hormone therapy. Observational studies and meta-analyses were stacking up, and the picture they painted was exciting — women on hormone therapy appeared to have a 40–50% lower risk of coronary heart disease. Not only that, but the data suggested potential protection against dementia and early death too.
The enthusiasm reached a peak in 1992 when the American College of Physicians officially recommended hormone therapy as a preventive strategy. It really did seem like a magic bullet.
But There Was a Catch
Here's the problem with those early studies: they were observational. That means researchers were watching what happened in real life rather than running a controlled experiment. And when you look closely at who was actually taking hormone therapy back then, a pattern emerges.
Women who sought out hormone therapy tended to be more educated, have higher incomes, and have better access to healthcare. All of those things — independent of any hormone — are also associated with better heart health outcomes. In research, we call these confounding variables, and they make it nearly impossible to know whether the hormones were actually doing anything, or whether these women were simply already in a better position to begin with.
It's a bit like noticing that people who carry umbrellas tend to get wet less often — and concluding that umbrellas cause rain. The logic doesn't hold.
Science Steps In
The medical community recognized the flaw and called for something more rigorous: randomized controlled trials (RCTs). In an RCT, women are randomly assigned to receive either hormone therapy or a placebo, which eliminates the "healthier women choose hormones" problem and gets us closer to the real answer.
Does hormone therapy actually cause a reduction in heart disease? Or had we been fooled by a coincidence?
The studies that followed would shake the entire field.
Key Takeaway from Part 1
The early excitement about MHT and heart health was real — but the evidence had a serious blind spot. Observational studies can tell us that two things are related, but not that one causes the other. To get to the truth, we needed better science.
Next up — Part 2: "The Hormone Scare of 2002 — Were We Right to Panic about our Hearts?"We'll look at the first major clinical trials, the shocking results that nobody saw coming, and the headlines that scared an entire generation of women away from hormone therapy overnight.